Abstract
Introduction: Sentinel node biopsy (SNB) has been increasingly performed for patients with lymph node (LN)-positive (cN1) breast cancer that converted to LN-negative (ycN0) status after neoadjuvant chemotherapy (NAC). This study aimed to clarify the SNB avoidance rates using fine needle aspiration cytology (FNAC) for metastatic LNs after NAC. Methods: This study included 68 patients with cN1 breast cancer undergoing NAC from April 2019 to August 2021. Patients with biopsy-proven metastatic clip-marked LNs (clipped LNs) underwent eight cycles of NAC. Ultrasonography (US) was performed to evaluate the effect of the treatment on the clipped LNs, and FNAC was performed after NAC. Patients with ycN0 status determined using FNAC underwent SNB. Those with positive results for FNAC or SNB underwent axillary LN dissection. Histopathology results and FNA were compared for clipped LNs after NAC. Results: Of the 68 cases, 53 were ycN0 and 15 were clinically positive LNs after NAC (ycN1) on US. Further, 13% (7/53) of all ycN0 and 60% (9/15) of all ycN1 cases showed residual metastasis in the LNs on FNAC. Conclusion: FNAC was diagnostically useful for patients with ycN0 status on US imaging. Using FNAC for LNs after NAC helped avoid unnecessary SNB in 13% of the cases.
Journal Section:
Fine Needle Aspiration
References
1.
Kim
JY
, Kim
MK
, Lee
JE
, Jung
Y
, Bae
SY
, Lee
SK
. Sentinel lymph node biopsy alone after neoadjuvant chemotherapy in patients with initial cytology-proven axillary node metastasis
. J Breast Cancer
. 2015
;18
(1
):22
–8
.2.
Noguchi
M
, Inokuchi
M
, Noguchi
M
, Morioka
E
, Ohno
Y
, Kurita
T
. Axillary surgery for breast cancer: past, present, and future
. Breast Cancer
. 2021
;28
(1
):9
–15
.3.
Akita
S
, Nakamura
R
, Yamamoto
N
, Tokumoto
H
, Ishigaki
T
, Yamaji
Y
. Early detection of lymphatic disorder and treatment for lymphedema following breast cancer
. Plast Reconstr Surg
. 2016
138
2
192e
202e
.4.
National Comprehensive Cancer Network (NCCN)
. Clinical practice guidelines in oncology: breast, version 2.2022
. BINV-D
. 2017
;2
:2022
. www.nccn.org. (accessed 18 Jan 2022).5.
Srour
MK
, Lee
M
, Walcott-Sapp
S
, Luu
M
, Chung
A
, Giuliano
AE
. Overuse of preoperative staging of patients undergoing neoadjuvant chemotherapy for breast cancer
. Ann Surg Oncol
. 2019
;26
(10
):3289
–94
.6.
Brackstone
M
, Baldassarre
FG
, Perera
FE
, Cil
T
, Chavez Mac Gregor
M
, Dayes
IS
. Management of the axilla in early-stage breast cancer: ontario health (cancer care ontario) and ASCO guideline
. J Clin Oncol
. 2021
;39
(27
):3056
–82
.7.
Boughey
JC
, Suman
VJ
, Mittendorf
EA
, Ahrendt
GM
, Wilke
LG
, Taback
B
. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
. JAMA
. 2013
;310
(14
):1455
–61
.8.
Boughey
JC
, Ballman
KV
, Le-Petross
HT
, McCall
LM
, Mittendorf
EA
, Ahrendt
GM
. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance)
. Ann Surg
. 2016
;263
(4
):802
–7
.9.
Boileau
JF
, Poirier
B
, Basik
M
, Holloway
CM
, Gaboury
L
, Sideris
L
. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study
. J Clin Oncol
. 2015
;33
(3
):258
–64
.10.
Kuehn
T
, Bauerfeind
I
, Fehm
T
, Fleige
B
, Hausschild
M
, Helms
G
. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
. Lancet Oncol
. 2013
;14
(7
):609
–18
.11.
Classe
JM
, Loaec
C
, Gimbergues
P
, Alran
S
, de Lara
CT
, Dupre
PF
. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study
. Breast Cancer Res Treat
. 2019
;173
(2
):343
–52
.12.
Caudle
AS
, Yang
WT
, Krishnamurthy
S
, Mittendorf
EA
, Black
DM
, Gilcrease
MZ
. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection
. J Clin Oncol
. 2016
;34
(10
):1072
–8
.13.
Turaga
KK
, Chau
A
, Eatrides
JM
, Kiluk
JV
, Khakpour
N
, Laronga
C
. Selective application of routine preoperative axillary ultrasonography reduces costs for invasive breast cancers
. Oncologist
. 2011
;16
(7
):942
–8
.14.
Susini
T
, Nori
J
, Olivieri
S
, Molino
C
, Marini
G
, Bianchi
S
. Predicting the status of axillary lymph nodes in breast cancer: amultiparameter approach including axillary ultrasound scanning
. Breast
. 2009
;18
(2
):103
–8
.15.
Alkuwari
E
, Auger
M
. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation
. Cancer
. 2008
;114
(2
):89
–93
.16.
Nakamura
R
, Yamamoto
N
, Miyaki
T
, Itami
M
, Shina
N
, Ohtsuka
M
. Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer
. Breast Cancer
. 2018
;25
(1
):86
–93
.17.
Shigekawa
T
, Sugitani
I
, Takeuchi
H
, Misumi
M
, Nakamiya
N
, Sugiyama
M
. Axillary ultrasound examination is useful for selecting patients optimally suited for sentinel lymph node biopsy after primary systemic chemotherapy
. Am J Surg
. 2012
;204
(4
):487
–93
.18.
Namura
M
, Tsunoda
H
, Kobayashi
D
, Enokido
K
, Yoshida
A
, Watanabe
T
. The loss of lymph node metastases after neoadjuvant chemotherapy in patients with cytology-proven axillary node-positive primary breast cancer
. Clin Breast Cancer
. 2019
;19
(4
):278
–85
.19.
Nakamura
R
, Hayama
S
, Sonoda
I
, Miyaki
T
, Itami
M
, Yamamoto
N
. Clinical impact of the biology of synchronous axillary lymph node metastases in primary breast cancer on preoperative treatment strategy
. J Surg Oncol
. 2021
;123
(7
):1513
–20
.20.
Sapino
A
, Cassoni
P
, Zanon
E
, Fraire
F
, Croce
S
, Coluccia
C
. Ultrasonographically guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management
. Br J Cancer
. 2003
;88
(5
):702
–6
.21.
Sakakibara
M
, Yokomizo
J
, Shiina
N
, Kazama
T
, Nakamura
R
, Fujimoto
H
. MRI-guided quadrantectomy in patients with ductal carcinoma in situ detected preoperatively by mammographic calcifications
. J Am Coll Surg
. 2014
;219
(2
):295
–302
.22.
Caudle
AS
, Kuerer
HM
, Krishnamurthy
S
, Shin
K
, Hobbs
BP
, Ma
J
. Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: a prospective registry study
. Cancer
. 2019
;125
(3
):365
–73
.23.
Alvarado
R
, Yi
M
, Le Petross
H
, Gilcrease
M
, Mittendorf
EA
, Bedrosian
I
. The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node positive breast cancer
. Ann Surg Oncol
. 2012
;19
(10
):3177
–84
.© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.
